TAKARA BIO INC.

2012.03.19: Takara Bio Submitted an Investigational New Drug (IND) Application for HIV-1 Gene Therapy to the Food and Drug Administration (FDA)
2011.10.31: Takara Bio to initiate a clinical development of gene therapy targeting non-Hodgkin lymphoma
2011.07.27: Starting up the gene therapy project in China
2011.04.27: Announcement of Takara Bio's mid-term management plan
2011.02.15: Takara Bio to establish a subsidiary for manufacturing and sales of research reagents in India